Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cellectar Biosciences, Inc. | Chief Financial Officer | Stock option (right to buy) | 422K | Jan 25, 2022 | Direct | ||
FEMASYS INC | Chief Financial Officer | Stock Option (Right to Buy) | 84K | Feb 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
FEMY | FEMASYS INC | Feb 1, 2024 | 1 | $0 | 4 | Feb 2, 2024 | Chief Financial Officer |
FEMY | FEMASYS INC | Jul 3, 2023 | 2 | $0 | 4 | Jul 3, 2023 | Chief Financial Officer |
FEMY | FEMASYS INC | Feb 28, 2022 | 1 | $0 | 4 | Mar 1, 2022 | Chief Financial Officer |
FEMY | FEMASYS INC | Feb 28, 2022 | 0 | $0 | 3 | Mar 1, 2022 | Chief Financial Officer |
CLRB | Cellectar Biosciences, Inc. | Jan 25, 2022 | 1 | $0 | 4 | Jan 27, 2022 | Chief Financial Officer |